This information is only intended for licensed healthcare professionals in Canada.

This website contains information intended only for licensed healthcare professionals in Canada.

Terms of Use  ·  Privacy Statement

Patient Resources

These resources can help patients continue the conversation after they leave your clinic. Share the resource that best fits what they need next.

When they need to understand what comes next

Right Your Story

A patient education resource for people navigating VWD and their treatment journey. Use it to help patients continue learning about their diagnosis, everyday life with VWD, and treatment after your conversation.

Open Right Your Story
When they want to know what support can look like

Wilate® ProCare Patient Guide

Provides an overview of the support available through the ProCare program. Share it with patients who are interested in self-infusion support.


Open Patient Guide

What does your patient need right now?

Explore a few common patient questions. Every patient's needs are different.

"I need more time to understand self-infusion. I'm not sure where to start."
This resource will help you explore the process in more detail.
Explore Right Your Story (opens in a new tab)
"I'm finding it difficult to keep track of my appointments and treatment."
ProCare team can do that for you. It includes an app that will help you stay organized between appointments and relay your progress to your treatment team.
Explore Patient Sync app (opens in a new tab)
"I still have questions about what support is available to me."
Here is more information about what you can expect through this program. If you have further questions, I can help you find the right information or support.
Explore Patient Guide (opens in a new tab)
"I feel ready to take to start the program."
I can get this started. We will fill in the enrollment form together.

Download enrollment form (opens in a new tab) and gather patient consent.

When you're ready, find the enrollment form here.

Send via email to wilate@bayshore.ca

Download Enrollment Form
New

Patient Sync App

View upcoming appointments
Order supplies
Track treatment progress
Important Safety Information

Indications

Von Willebrand disease (VWD)

Wilate® is indicated for:

  • Treatment and prophylaxis of spontaneous and trauma-induced bleeds in all types of VWD in adult and pediatric patients where use of DDAVP (1-deamino-8-D-arginine vasopressin/desmopressin) treatment is ineffective or contra-indicated.
    Clinical data on controlling severe spontaneous bleeding are limited.
  • Prevention and treatment of bleeding during and after surgical procedures.
Hemophilia A

Wilate® is indicated for:

  • Treatment and prophylaxis of bleeding in patients with hemophilia A (congenital or acquired FVIII deficiency) and for the prevention and treatment of bleeding in minor surgical procedures. Clinical trials to evaluate the safety and efficacy of Wilate® in major surgeries are ongoing. Therefore, limited data are presently available on which to evaluate or to base dosing recommendations. Thus, in the case of major surgical interventions, a precise monitoring of the substitution therapy by means of coagulation analysis (FVIII:C) is indispensable.

Contraindications

Wilate® is contraindicated for patients who are hypersensitive to this drug or to any ingredient in the formulation, including any non-medicinal ingredient, or component of the container.

For full Prescribing Information, Indications, and Adverse Reactions, please refer to the Wilate® Product Monograph.

1-844-453-1893
wilate@bayshore.ca
This information is only intended for licensed healthcare professionals in Canada.